Skip to content

A clinical study to evaluate the effects of beverage containing green tea catechins on reducing LDL cholesterol

A clinical study to evaluate the effects of beverage containing green tea catechins on reducing LDL cholesterol - A clinical study to evaluate the effects of beverage containing green tea catechins on reducing LDL cholesterol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031224
Enrollment
140
Registered
2019-02-09
Start date
2018-02-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of beverage containing green tea catechins for 12 weeks Intake of placebo for 12 weeks

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects whose age of 20 years or more and less than 65 years 2) Subjects whose serum LDL cholesterol levels are 120 mg/dL or more and less than 140 mg/dL (borderline) or 140 mg/dL or more and less than 160 mg/dL (mild Hypercholesterolemia) in the screening examination 3) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects receiving a medical treatment for dyslipidemia 2) Subjects having serious hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders 3) Subjects whose fasting serum triglyceride levels are 400 mg/dL or more 4) Subjects who have the possibility of developing allergic symptoms by the test food 5) Subjects who take Foods for Specified Health Uses or Foods with Function Claims labeled the effects of improving LDL cholesterol or total cholesterol levels 6) Subjects who take foods having the effects of improving LDL cholesterol or total cholesterol levels 7) Female subjects who are pregnant or lactating, or intending to be pregnant during the study 8) Female subjects who have menstrual irregularities 9) Subjects who have extremely irregular dietary habits, work in shifts or work during the night 10) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 11) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 12) Subjects deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
LDL cholesterol

Secondary

MeasureTime frame
Total cholesterol, HDL cholesterol, LOX-index

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. Representative Director

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026